CHHHF Stock Chart & Stats
$2.34
-$0.09(-3.53%)
At close: 4:00 PM EDT
$2.34
-$0.09(-3.53%)
Day’s Range― - ―
52-Week Range$2.23 - $2.89
Previous CloseN/A
Volume10.10K
Average Volume (3M)27.00
Market Cap
$145.96M
Enterprise Value$291.62
Total Cash (Recent Filing)$10.05M
Total Debt (Recent Filing)$76.33M
Price to Earnings (P/E)7.4
Beta0.05
Next Earnings
Nov 11, 2026EPS Estimate
0.03Next Dividend Ex-DateN/A
Dividend Yield2.47%
Share Statistics
EPS (TTM)0.42
Shares Outstanding63,514,038
10 Day Avg. Volume0
30 Day Avg. Volume27
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)2.19
Price to Sales (P/S)0.65
P/FCF Ratio10.92
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$3.43Price Target Upside46.47% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.1
Revenue Forecast (FY)$272.88M
Bulls Say, Bears Say
Bulls Say
Return To ProfitabilityThe return to profitability marks a meaningful improvement in CareRx’s earnings profile after prior losses. Positive net income provides greater capacity to fund operations, support capital allocation, and absorb moderate business volatility while the company continues expanding its serviced-bed base.
Contracted Bed GrowthAdding approximately 3,000 retirement beds through a long-term agreement should expand recurring prescription volumes and pharmacy-service revenue. Because the contract is tied to a national seniors-home operator and is expected to be margin-accretive over time, it supports scale and strengthens CareRx’s institutional market position.
Cash GenerationStrong trailing cash generation and free-cash-flow conversion provide evidence that reported profitability is translating into internally generated funds. This supports debt service, operating investment, and continued network expansion, while reducing reliance on external financing for routine business needs.
Bears Say
Ontario Funding HeadwindThe Ontario funding change creates a multi-period revenue drag rather than a single-quarter fluctuation. The delayed recovery, contingent on ward-bed redevelopment and not expected until late 2027, can weigh on near-term earnings, cash generation, and the pace at which operating improvements translate into results.
Thin Operating MarginsCareRx remains profitable, but modest EBIT and EBITDA margins leave limited protection if funding pressure, costs, or volume growth move unfavorably. Thin operating leverage means relatively small changes in revenue or expenses can have a disproportionate effect on earnings and reduce flexibility during the recovery period.
Lower Cash And Higher Net DebtThe quarter-end decline in cash alongside higher net debt reduces financial flexibility compared with the prior quarter. Although leverage remains moderate, weaker liquidity and increased borrowings could constrain investment or shareholder distributions if funding pressure persists or cash conversion becomes more volatile.
CareRx News
CHHHF FAQ
What was CareRx’s price range in the past 12 months?
CareRx lowest stock price was $2.23 and its highest was $2.89 in the past 12 months.
What is CareRx’s market cap?
CareRx’s market cap is $145.96M.
When is CareRx’s upcoming earnings report date?
CareRx’s upcoming earnings report date is Nov 11, 2026 which is in 58 days.
How were CareRx’s earnings last quarter?
CareRx released its earnings results on Jul 29, 2026. The company reported $0.007 earnings per share for the quarter, missing the consensus estimate of $0.017 by -$0.009.
Is CareRx overvalued?
According to Wall Street analysts CareRx’s price is currently Undervalued.
Does CareRx pay dividends?
CareRx pays a Quarterly dividend of $0.016 which represents an annual dividend yield of 2.47%. See more information on CareRx dividends here
What is CareRx’s EPS estimate?
CareRx’s EPS estimate is 0.03.
How many shares outstanding does CareRx have?
CareRx has 63,514,038 shares outstanding.
What happened to CareRx’s price movement after its last earnings report?
CareRx reported an EPS of $0.007 in its last earnings report, missing expectations of $0.017. Following the earnings report the stock price went up 3.696%.
Which hedge fund is a major shareholder of CareRx?
Currently, no hedge funds are holding shares in CHHHF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CareRx Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.43 (46.47% Upside)
$3.43 (46.47% Upside)
Insider Transactions
Bought Shares
Worth $22.8K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
1.62%
12-Months-Change
Fundamentals
Return on Equity
2.47%
Trailing 12-Months
Asset Growth
11.38%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
CareRx
CareRx Corporation, operating with its subsidiaries, specializes in delivering tailored pharmaceutical services to Canada's senior demographic. The company manages a vast network of medication dispensing facilities, which are responsible for providing chronic prescriptions and a variety of other advanced clinical pharmacy solutions. Currently, it caters to approximately 50,000 individuals residing in roughly 900 distinct senior and communal living environments, including extended care residences, retirement communities, supportive living facilities, and group homes. Founded in 2001 and based in Toronto, Canada, the corporation rebranded as CareRx Corporation in June 2020, having formerly been known as Centric Health Corporation.
CHHHF Stock 12 Month Forecast
Average Price Target
$3.43
▲(46.47% Upside)
Technical Analysis
Extendicare
―
Nova Leap Health
―
Sienna Senior Living
―
Medical Facilities
―
WELL Health Technologies Corp
―